Newsfeeds - Spark Newswire

2 minute read

Kintara Therapeutics Presents Data At 2022 Annual Meeting

Today, 2:09 PM

Kintara Therapeutics, Inc. (NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that it

KTRA

2 minute read

4 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 2:09 PM

U.S. existing home sales surged 6.7% to an annual rate of 6.5 million in January. Investors, meanwhile, focused on some notable insider trades.

IMRA

1 minute read

Earnings

Kintara Therapeutics: Q2 Earnings Insights

By Benzinga Insights

Today, 2:09 PM

Kintara Therapeutics (NASDAQ:KTRA) reported its Q2 earnings results on Friday, February 11, 2022 at 08:15 AM. Here's what investors need to know about the announcement.

KTRA

2 minute read

20 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 2:09 PM

Gainers

APM

4 minute read

53 Biggest Movers From Friday

By Lisa Levin

Today, 2:09 PM

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday.

ACXP

1 minute read

HC Wainwright & Co. Maintains Buy on Kintara Therapeutics, Lowers Price Target to $3

By Benzinga Newsdesk

Today, 2:09 PM

HC Wainwright & Co. analyst Michael King maintains Kintara Therapeutics (NASDAQ:KTRA) with a Buy and lowers the price target from $6 to $3.

KTRA

4 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 2:09 PM

On Wednesday, 41 stocks made new 52-week lows.

AVGR

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 2:09 PM

ABEO

2 minute read

3 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 2:09 PM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CLRD

2 minute read

Kintara Therapeutics Highlights Presentation Of Updates On 2 Phase 2 Studies At ‘Society For Neuro-Oncology’ Meeting Nov. 18-21

By Benzinga Newsdesk

Today, 2:09 PM

Kintara Therapeutics, Inc. (NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced data from

KTRA